Breedlove Robert Charles (CIK 2066645) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy PHAT (13,000 shares), Buy PHAT (2,790 shares), Sell PHAT (964 shares), Sell PHAT (414 shares), Sell PHAT (776 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Phathom Pharmaceuticals, Inc. (PHAT) | Principal Accounting Officer | Buy | 13,000 | $0 |
| 2026-03-03 | Phathom Pharmaceuticals, Inc. (PHAT) | Principal Accounting Officer | Buy | 2,790 | $0 |
| 2026-03-03 | Phathom Pharmaceuticals, Inc. (PHAT) | Principal Accounting Officer | Sell | 964 | $12,108 |
| 2026-03-03 | Phathom Pharmaceuticals, Inc. (PHAT) | Principal Accounting Officer | Sell | 414 | $5,200 |
| 2026-01-23 | Phathom Pharmaceuticals, Inc. (PHAT) | Principal Accounting Officer | Sell | 776 | $10,561 |
| 2025-12-19 | Phathom Pharmaceuticals, Inc. (PHAT) | Principal Accounting Officer | Sell | 230 | $3,744 |
| 2025-11-05 | Phathom Pharmaceuticals, Inc. (PHAT) | Principal Accounting Officer | Sell | 524 | $7,079 |
| 2025-09-09 | Phathom Pharmaceuticals, Inc. (PHAT) | Principal Accounting Officer | Sell | 461 | $5,573 |
| 2025-07-18 | Phathom Pharmaceuticals, Inc. (PHAT) | Principal Accounting Officer | Sell | 1,692 | $14,145 |
Source: SEC Form 4 filings · as of 2026-03-03